PROMOPHARM S.A

Last Updated:
  • 976.20 MAD
  • 0.00
  • 0.00%
شركة الإنعاش الصيدلي للمغرب
بروموفارم
Symbol : PRO
ISIN : MA0000011660
52-Week Range : 921.00 - 1,110.00
Turnover Ratio : 0.00
Market : Casablanca Stock Exchange
Sector : Pharmaceuticals
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Basic Information

  • Activity :
    Societe de Promotion Pharmaceutique du Maghreb (known as: Promopharm SA) is a public company, listed on Casablanca Stock Exchange since June 2007. PROMOPHARM operates within the pharmaceuticals, biotechnology...
  • Industry Group :
    pharmaceuticals Research and Biotechnology
  • Sub-Industry :
  • ISIN :
    MA0000011660
  • Contact Person :
  • Established On:
    28-Aug-1947
  • Stock Listing On :
    15-Jun-2007
  • No of Employees :
    --
  • Outstanding Shares :
    1,000,000
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :

Indices Membership

Action Date Index Provider
Leave 2019 MADEX Casablanca Stock Exchange
Join 2016 MADEX Casablanca Stock Exchange
Join 2013 MASI Casablanca Stock Exchange
Join 2007 MASI Pharmaceutical Industry Casablanca Stock Exchange
Societe de Promotion Pharmaceutique du Maghreb
Street 7. industrial zone of the Sahel. BP 96/97. 26 400. Had Soualem. - Berrechid - Morocco
T : +212 5 22964567
F : +212 5 22964701
www.promopharm.co.ma
niken@hikma.com

Management

Title Name As Of
Chairman: Mazen Darwazah 2013
Board Member: Mazen Derwazeh 2012
Brahim Olammou 2014
Bassam Kanaan 2012
Salah Al Mawajdeh 2012

Reports

Date Title File
2024 Promopharm Press Release
2023 Promopharm SA Quarterly Financials Report Q2 2023
2023 Promopharm SA Annual Financials Report 2022
2022 Promopharm SA Annual Financials Report 2021
2021 Promopharm SA Quarterly Financials Report Q2 2021
2021 Promopharm SA Quarterly Financials Report Q2 2021
2021 Promopharm SA Annual Financials Report 2020
2020 Promopharm SA Quarterly Financials Report Q2 2020
2020 Promopharm SA Annual Financials Report 2019
2019 Promopharm SA Quarterly Financials Report Q2 2019
2019 Promopharm Annual Financials Report 2018
Check our coverage for